Edwards Lifesciences Corp (EW)
89.14
-0.97
(-1.08%)
USD |
NYSE |
May 17, 16:00
89.15
+0.01
(+0.01%)
After-Hours: 20:00
Edwards Lifesciences Accounts Receivable (Quarterly): 817.60M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 817.60M |
| December 31, 2023 | 775.10M |
| September 30, 2023 | 739.80M |
| June 30, 2023 | 754.40M |
| March 31, 2023 | 717.70M |
| December 31, 2022 | 643.00M |
| September 30, 2022 | 618.10M |
| June 30, 2022 | 636.40M |
| March 31, 2022 | 636.30M |
| December 31, 2021 | 582.20M |
| September 30, 2021 | 600.60M |
| June 30, 2021 | 640.50M |
| March 31, 2021 | 586.60M |
| December 31, 2020 | 514.60M |
| September 30, 2020 | 549.70M |
| June 30, 2020 | 567.90M |
| March 31, 2020 | 585.10M |
| December 31, 2019 | 543.60M |
| September 30, 2019 | 570.00M |
| June 30, 2019 | 609.60M |
| March 31, 2019 | 578.00M |
| December 31, 2018 | 456.90M |
| September 30, 2018 | 423.80M |
| June 30, 2018 | 431.40M |
| March 31, 2018 | 406.60M |
| Date | Value |
|---|---|
| December 31, 2017 | 438.70M |
| September 30, 2017 | 475.00M |
| June 30, 2017 | 510.70M |
| March 31, 2017 | 510.20M |
| December 31, 2016 | 365.50M |
| September 30, 2016 | 454.20M |
| June 30, 2016 | 425.80M |
| March 31, 2016 | 388.50M |
| December 31, 2015 | 315.40M |
| September 30, 2015 | 338.40M |
| June 30, 2015 | 351.00M |
| March 31, 2015 | 345.30M |
| December 31, 2014 | 288.00M |
| September 30, 2014 | 322.90M |
| June 30, 2014 | 327.50M |
| March 31, 2014 | 305.10M |
| December 31, 2013 | 302.50M |
| September 30, 2013 | 327.80M |
| June 30, 2013 | 341.80M |
| March 31, 2013 | 329.70M |
| December 31, 2012 | 321.10M |
| September 30, 2012 | 325.40M |
| June 30, 2012 | 336.40M |
| March 31, 2012 | 346.70M |
| December 31, 2011 | 283.80M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
514.60M
Minimum
Dec 2020
817.60M
Maximum
Mar 2024
634.44M
Average
613.85M
Median
Accounts Receivable (Quarterly) Benchmarks
| Stryker Corp | 3.473B |
| Align Technology Inc | 950.74M |
| Abbott Laboratories | 6.605B |
| Boston Scientific Corp | 2.304B |
| Steris PLC | 1.008B |